Gary Owens
11Patents
4h-index
16Co-inventors
57Inventor score
Filing activity: Jul 13, 2000 → Jul 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7713573B2 | Method for loading nanoporous layers with therapeutic agent | Human Necessities | 21 | Active |
| US8449602B2 | Methods for using a stent having nanoporous layers | Human Necessities | 9 | Active |
| US8124166B2 | Method for loading nanoporous layers with therapeutic agent | Human Necessities | 6 | Active |
| US9770349B2 | Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation | Human Necessities | 4 | Active |
| US8623066B2 | Cell seeded expandable body | Human Necessities | 4 | Active |
| US6780610B1 | Identification of a smooth muscle cell (SMC) specific smooth muscle heavy chain (SM-MHC) promoter/enhancer | Chemistry; Metallurgy | 1 | Expired |
| US11753630B2 | Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene | Chemistry; Metallurgy | 0 | Active |
| US6825035B1 | Compositions and methods for modulating expression within smooth muscle cells | Human Necessities | 0 | Expired |
| US12006522B2 | Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene | Chemistry; Metallurgy | 0 | Active |
| US11993793B2 | Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene | Chemistry; Metallurgy | 0 | Active |
| US6914136B2 | Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.